文献速递类风湿关节炎

类风湿关节炎患者中心肌梗死和严重感染的生物标志物相关风险:一项基于人群的研究

Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study.
PubMed 文献 · Ann Rheum Dis · 2017-12-21

基于美国大规模人群的类风湿关节炎(RA)患者数据,将多生物标志物疾病活动度(MBDA)评分与联邦医疗保险(Medicare)数据链接,分析MBDA评分与住院肺炎/脓毒症(SIE)、心肌梗死(MI)及冠心病(CHD)事件的关联。结果显示较高的MBDA评分与SIE风险升高相关,MI/CHD事件呈现阈值效应,去除C反应蛋白(CRP)后结果相似。

要点

  • MBDA评分每变化10单位,严重感染风险HR=1.32(95%CI 1.23至1.41)。
  • MBDA评分≥30 vs <30时,MI风险HR=1.52(95%CI 0.92至2.49),CHD风险HR=1.54(95%CI 1.01至2.34)。
  • 从MBDA评分中去除CRP后分析结果相似。

核心结论

  • 在大型、以老年为主的美国RA人群中,较高的MBDA评分与住院感染、MI和CHD事件相关。

研究设计与样本

  • 基于人群的研究,将MBDA检测评分(n=77 641)与美国联邦医疗保险(Medicare)数据链接,纳入美国RA患者。
  • MBDA评分范围为1至100,作为时变变量分析;采用Cox比例风险模型评估MBDA评分与SIE、MI及CHD事件的关联,并控制潜在混杂因素。
  • 敏感性分析从MBDA评分中排除C反应蛋白(CRP)。

主要发现

  • SIE分析纳入17 433例患者,MI/CHD分析纳入16 796例患者;平均(SD)年龄69(11)岁,79%为女性,81%为白人,38%为残疾。
  • 随访16 424人年期间,发生452例SIE事件、132例MI和181例CHD事件。
  • MBDA评分每变化10单位,与SIE风险升高相关(HR=1.32,95%CI 1.23至1.41)。
  • 比较MBDA评分≥30 vs <30,MI风险HR=1.52(95%CI 0.92至2.49),CHD风险HR=1.54(95%CI 1.01至2.34),呈阈值效应。
  • 从MBDA评分中去除CRP后分析结果相似。

关键数值与推荐

  • MBDA评分每变化10单位与SIE的HR=1.32(95%CI 1.23至1.41)。
  • MBDA评分≥30 vs <30与MI的HR=1.52(95%CI 0.92至2.49)。
  • MBDA评分≥30 vs <30与CHD的HR=1.54(95%CI 1.01至2.34)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rheumatoid arthritis (RA) disease activity and associated systemic inflammation has been associated with serious infection (SIEs), myocardial infarction (MI) and coronary heart disease (CHD) events based on a few registry studies or clinical trials. There are few data from large-scale population-based studies given feasibility challenges in conducting such investigations. METHODS: Multibiomarker disease activity (MBDA) test scores (n=77 641) were linked to Medicare for US patients with RA. Outcomes of interest were hospitalised pneumonia/sepsis (SIE), MI and a composite CHD outcome. The MBDA score ranges from 1 to 100 and was analysed as time-varying. Cox proportional hazards models evaluated the association between MBDA score and SIEs, MI and CHD events, controlling for potential confounders. A sensitivity analysis excluded C reactive protein (CRP) from the MBDA score. RESULTS: There were 17 433 and 16 796 patients eligible for the SIE and MI/CHD analyses, respectively. Mean (SD) age was 69 (11) years, 79% were women, 81% were white and 38% were disabled. Over 16 424 person-years of follow-up, there were 452 SIE events, 132 MIs and 181 CHD events. Higher MBDA scores were associated with SIEs (HR=1.32, 95% CI 1.23 to 1.41 per 10 unit MBDA score change). For MI/CHD events, a threshold effect was present; higher disease activity by MBDA score was associated with increased MI (HR=1.52, 95% CI 0.92 to 2.49) and CHD rates (HR=1.54, 95% CI 1.01 to 2.34, comparing scores ≥30 vs <30). Analyses of the MBDA score without CRP yielded similar results. CONCLUSION: Higher MBDA scores were associated with hospitalised infection, MI and CHD events in a large, predominantly older, US RA population.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Curtis JR, Xie F, Chen L, et al. Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study. Ann Rheum Dis. 2017. PMID: 29269418. doi:10.1136/annrheumdis-2017-211727

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。